ID   EOGT_HUMAN              Reviewed;         527 AA.
AC   Q5NDL2; A8K2U1; B4DFH5; L7X1M5; Q6MZY0; Q6P985; Q6ZTV0;
DT   11-SEP-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-2005, sequence version 1.
DT   28-JUN-2023, entry version 132.
DE   RecName: Full=EGF domain-specific O-linked N-acetylglucosamine transferase;
DE            EC=2.4.1.255 {ECO:0000250|UniProtKB:Q8BYW9};
DE   AltName: Full=Extracellular O-linked N-acetylglucosamine transferase;
DE   Flags: Precursor;
GN   Name=EOGT; Synonyms=AER61, C3orf64, EOGT1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, AND MUTAGENESIS OF
RP   295-ASP--ASP-297.
RC   TISSUE=Embryonic kidney;
RX   PubMed=23671640; DOI=10.1371/journal.pone.0062835;
RA   Muller R., Jenny A., Stanley P.;
RT   "The EGF repeat-specific O-GlcNAc-transferase Eogt interacts with Notch
RT   signaling and pyrimidine metabolism pathways in Drosophila.";
RL   PLoS ONE 8:E62835-E62835(2013).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Kiefer-Meyer M.C., Pagny S., Durambure G., Faye L., Gomord V.,
RA   Mollicone R., Oriol R.;
RT   "Phylogeny of xylosyltransferases.";
RL   Submitted (DEC-2004) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Brain cortex, Thymus, and Tongue;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA] OF 102-527.
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R., Buhay C.J.,
RA   Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R., Gunaratne P.,
RA   Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V., Hume J., Jackson A.,
RA   Khan Z.M., Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Morgan M.B., Nazareth L.V., Scott G.,
RA   Sodergren E., Song X.-Z., Steffen D., Wei S., Wheeler D.A., Wright M.W.,
RA   Worley K.C., Yuan Y., Zhang Z., Adams C.Q., Ansari-Lari M.A., Ayele M.,
RA   Brown M.J., Chen G., Chen Z., Clendenning J., Clerc-Blankenburg K.P.,
RA   Chen R., Chen Z., Davis C., Delgado O., Dinh H.H., Dong W., Draper H.,
RA   Ernst S., Fu G., Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J.,
RA   Hao B., Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W.,
RA   Jackson L.R., Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B.,
RA   Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V., Okwuonu G.O.,
RA   Palmeiri A., Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K.-S., Yao Z., Zhang J., Zhang X.,
RA   Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H., Reinhardt R.,
RA   Naylor S.L., Yang H., Olson M., Weinstock G., Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 69-527 (ISOFORM 1).
RC   TISSUE=Esophageal carcinoma;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [7]
RP   VARIANTS AOS4 SER-207 AND GLN-377.
RX   PubMed=23522784; DOI=10.1016/j.ajhg.2013.02.012;
RA   Shaheen R., Aglan M., Keppler-Noreuil K., Faqeih E., Ansari S., Horton K.,
RA   Ashour A., Zaki M.S., Al-Zahrani F., Cueto-Gonzalez A.M., Abdel-Salam G.,
RA   Temtamy S., Alkuraya F.S.;
RT   "Mutations in EOGT confirm the genetic heterogeneity of autosomal-recessive
RT   Adams-Oliver syndrome.";
RL   Am. J. Hum. Genet. 92:598-604(2013).
CC   -!- FUNCTION: Catalyzes the transfer of a single N-acetylglucosamine from
CC       UDP-GlcNAc to a serine or threonine residue in extracellular proteins
CC       resulting in their modification with a beta-linked N-acetylglucosamine
CC       (O-GlcNAc). Specifically glycosylates the Thr residue located between
CC       the fifth and sixth conserved cysteines of folded EGF-like domains.
CC       {ECO:0000269|PubMed:23671640}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=L-seryl-[protein] + UDP-N-acetyl-alpha-D-glucosamine = 3-O-(N-
CC         acetyl-beta-D-glucosaminyl)-L-seryl-[protein] + H(+) + UDP;
CC         Xref=Rhea:RHEA:48904, Rhea:RHEA-COMP:9863, Rhea:RHEA-COMP:12251,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:57705,
CC         ChEBI:CHEBI:58223, ChEBI:CHEBI:90838; EC=2.4.1.255;
CC         Evidence={ECO:0000250|UniProtKB:Q8BYW9};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=L-threonyl-[protein] + UDP-N-acetyl-alpha-D-glucosamine = 3-O-
CC         (N-acetyl-beta-D-glucosaminyl)-L-threonyl-[protein] + H(+) + UDP;
CC         Xref=Rhea:RHEA:48908, Rhea:RHEA-COMP:11060, Rhea:RHEA-COMP:12252,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:30013, ChEBI:CHEBI:57705,
CC         ChEBI:CHEBI:58223, ChEBI:CHEBI:90840; EC=2.4.1.255;
CC         Evidence={ECO:0000250|UniProtKB:Q8BYW9};
CC   -!- INTERACTION:
CC       Q5NDL2-3; Q5JX71: FAM209A; NbExp=3; IntAct=EBI-13052900, EBI-18304435;
CC       Q5NDL2-3; Q9UKG4: SLC13A4; NbExp=3; IntAct=EBI-13052900, EBI-12808018;
CC       Q5NDL2-3; Q8TBB6: SLC7A14; NbExp=3; IntAct=EBI-13052900, EBI-5235586;
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum lumen {ECO:0000255|PROSITE-
CC       ProRule:PRU10138}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q5NDL2-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q5NDL2-2; Sequence=VSP_027897, VSP_027898;
CC       Name=3;
CC         IsoId=Q5NDL2-3; Sequence=VSP_027899;
CC   -!- DISEASE: Adams-Oliver syndrome 4 (AOS4) [MIM:615297]: A form of Adams-
CC       Oliver syndrome, a disorder characterized by the congenital absence of
CC       skin (aplasia cutis congenita) in combination with transverse limb
CC       defects. Aplasia cutis congenita can be located anywhere on the body,
CC       but in the vast majority of the cases, it is present on the posterior
CC       parietal region where it is often associated with an underlying defect
CC       of the parietal bones. Limb abnormalities are typically limb truncation
CC       defects affecting the distal phalanges or entire digits (true
CC       ectrodactyly). Only rarely, metatarsals/metacarpals or more proximal
CC       limb structures are also affected. Apart from transverse limb defects,
CC       syndactyly, most commonly of second and third toes, can also be
CC       observed. The clinical features are highly variable and can also
CC       include cardiovascular malformations, brain abnormalities and vascular
CC       defects such as cutis marmorata and dilated scalp veins.
CC       {ECO:0000269|PubMed:23522784}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the glycosyltransferase 61 family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAF83045.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=BAG57436.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; KC347596; AGC92970.1; -; mRNA.
DR   EMBL; AJ868234; CAI30569.1; -; mRNA.
DR   EMBL; AK126187; BAC86479.1; -; mRNA.
DR   EMBL; AK290356; BAF83045.1; ALT_INIT; mRNA.
DR   EMBL; AK294101; BAG57436.1; ALT_INIT; mRNA.
DR   EMBL; AC109587; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC060887; AAH60887.1; -; mRNA.
DR   EMBL; BX640821; CAE45897.2; -; mRNA.
DR   CCDS; CCDS2908.1; -. [Q5NDL2-3]
DR   CCDS; CCDS63684.1; -. [Q5NDL2-1]
DR   RefSeq; NP_001265618.1; NM_001278689.1. [Q5NDL2-1]
DR   RefSeq; NP_775925.1; NM_173654.2. [Q5NDL2-3]
DR   RefSeq; XP_005264800.1; XM_005264743.2. [Q5NDL2-1]
DR   RefSeq; XP_016861694.1; XM_017006205.1. [Q5NDL2-1]
DR   RefSeq; XP_016861695.1; XM_017006206.1. [Q5NDL2-1]
DR   AlphaFoldDB; Q5NDL2; -.
DR   SMR; Q5NDL2; -.
DR   BioGRID; 130045; 77.
DR   IntAct; Q5NDL2; 23.
DR   STRING; 9606.ENSP00000373206; -.
DR   CAZy; GT61; Glycosyltransferase Family 61.
DR   GlyCosmos; Q5NDL2; 1 site, No reported glycans.
DR   GlyGen; Q5NDL2; 2 sites, 1 O-linked glycan (1 site).
DR   iPTMnet; Q5NDL2; -.
DR   PhosphoSitePlus; Q5NDL2; -.
DR   BioMuta; EOGT; -.
DR   DMDM; 74708096; -.
DR   EPD; Q5NDL2; -.
DR   jPOST; Q5NDL2; -.
DR   MassIVE; Q5NDL2; -.
DR   MaxQB; Q5NDL2; -.
DR   PaxDb; Q5NDL2; -.
DR   PeptideAtlas; Q5NDL2; -.
DR   ProteomicsDB; 1853; -.
DR   ProteomicsDB; 63594; -. [Q5NDL2-1]
DR   ProteomicsDB; 63595; -. [Q5NDL2-2]
DR   ProteomicsDB; 63596; -. [Q5NDL2-3]
DR   Antibodypedia; 15479; 70 antibodies from 17 providers.
DR   DNASU; 285203; -.
DR   Ensembl; ENST00000295571.9; ENSP00000295571.5; ENSG00000163378.14. [Q5NDL2-3]
DR   Ensembl; ENST00000383701.8; ENSP00000373206.3; ENSG00000163378.14. [Q5NDL2-1]
DR   Ensembl; ENST00000540764.5; ENSP00000443780.2; ENSG00000163378.14. [Q5NDL2-1]
DR   Ensembl; ENST00000540955.5; ENSP00000444264.2; ENSG00000163378.14. [Q5NDL2-3]
DR   GeneID; 285203; -.
DR   KEGG; hsa:285203; -.
DR   MANE-Select; ENST00000383701.8; ENSP00000373206.3; NM_001278689.2; NP_001265618.1.
DR   UCSC; uc003dnk.5; human. [Q5NDL2-1]
DR   AGR; HGNC:28526; -.
DR   CTD; 285203; -.
DR   DisGeNET; 285203; -.
DR   GeneCards; EOGT; -.
DR   GeneReviews; EOGT; -.
DR   HGNC; HGNC:28526; EOGT.
DR   HPA; ENSG00000163378; Low tissue specificity.
DR   MalaCards; EOGT; -.
DR   MIM; 614789; gene.
DR   MIM; 615297; phenotype.
DR   neXtProt; NX_Q5NDL2; -.
DR   OpenTargets; ENSG00000163378; -.
DR   Orphanet; 974; Adams-Oliver syndrome.
DR   PharmGKB; PA143485338; -.
DR   VEuPathDB; HostDB:ENSG00000163378; -.
DR   eggNOG; KOG4698; Eukaryota.
DR   GeneTree; ENSGT00940000156493; -.
DR   HOGENOM; CLU_039300_0_0_1; -.
DR   InParanoid; Q5NDL2; -.
DR   OMA; GHCELNR; -.
DR   OrthoDB; 316918at2759; -.
DR   PhylomeDB; Q5NDL2; -.
DR   TreeFam; TF313716; -.
DR   BRENDA; 2.4.1.255; 2681.
DR   PathwayCommons; Q5NDL2; -.
DR   SignaLink; Q5NDL2; -.
DR   BioGRID-ORCS; 285203; 9 hits in 1152 CRISPR screens.
DR   ChiTaRS; EOGT; human.
DR   GenomeRNAi; 285203; -.
DR   Pharos; Q5NDL2; Tbio.
DR   PRO; PR:Q5NDL2; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   RNAct; Q5NDL2; protein.
DR   Bgee; ENSG00000163378; Expressed in blood vessel layer and 183 other tissues.
DR   ExpressionAtlas; Q5NDL2; baseline and differential.
DR   Genevisible; Q5NDL2; HS.
DR   GO; GO:0005788; C:endoplasmic reticulum lumen; IBA:GO_Central.
DR   GO; GO:0097363; F:protein O-acetylglucosaminyltransferase activity; ISS:UniProtKB.
DR   GO; GO:0097370; P:protein O-GlcNAcylation via threonine; IBA:GO_Central.
DR   GO; GO:0006493; P:protein O-linked glycosylation; ISS:UniProtKB.
DR   InterPro; IPR007657; Glycosyltransferase_61.
DR   PANTHER; PTHR20961:SF124; EGF DOMAIN-SPECIFIC O-LINKED N-ACETYLGLUCOSAMINE TRANSFERASE; 1.
DR   PANTHER; PTHR20961; GLYCOSYLTRANSFERASE; 1.
DR   Pfam; PF04577; Glyco_transf_61; 1.
DR   PROSITE; PS00014; ER_TARGET; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Disease variant; Endoplasmic reticulum; Glycoprotein;
KW   Glycosyltransferase; Reference proteome; Signal; Transferase.
FT   SIGNAL          1..17
FT                   /evidence="ECO:0000255"
FT   CHAIN           18..527
FT                   /note="EGF domain-specific O-linked N-acetylglucosamine
FT                   transferase"
FT                   /id="PRO_0000301970"
FT   MOTIF           295..297
FT                   /note="Required for optimal activity"
FT   MOTIF           524..527
FT                   /note="Prevents secretion from ER"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU10138"
FT   CARBOHYD        354
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   VAR_SEQ         208
FT                   /note="F -> C (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_027897"
FT   VAR_SEQ         209..527
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_027898"
FT   VAR_SEQ         278..361
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_027899"
FT   VARIANT         207
FT                   /note="W -> S (in AOS4; dbSNP:rs587776993)"
FT                   /evidence="ECO:0000269|PubMed:23522784"
FT                   /id="VAR_070090"
FT   VARIANT         377
FT                   /note="R -> Q (in AOS4; dbSNP:rs587776995)"
FT                   /evidence="ECO:0000269|PubMed:23522784"
FT                   /id="VAR_070091"
FT   MUTAGEN         295..297
FT                   /note="DYD->AYA: Partial loss of activity."
FT                   /evidence="ECO:0000269|PubMed:23671640"
FT   CONFLICT        199
FT                   /note="Q -> R (in Ref. 3; BAC86479)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        247
FT                   /note="Y -> C (in Ref. 6; CAE45897)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        287
FT                   /note="S -> F (in Ref. 3; BAG57436)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   527 AA;  62011 MW;  C34D267187BFDDA9 CRC64;
     MLMLFVFGVL LHEVSLSGQN EAPPNTHSIP GEPLYNYASI RLPEEHIPFF LHNNRHIATV
     CRKDSLCPYK KHLEKLKYCW GYEKSCKPEF RFGYPVCSYV DMGWTDTLES AEDIFWKQAD
     FGYARERLEE MHVLCQPKET SDSSLVCSRY LQYCRATNLY LDLRNIKRNH DRFKEDFFQS
     GEIGGHCKLD IRTLTSEGQR KSPLQSWFAE LQSYTQLNFR PIEDAKCDIV IEKPTYFMKL
     DAGVNMYHHF CDFINLYITQ HVNNSFSTDV YIVMWDTSSY GYGDLFSDTW NAFTDYDVIH
     LKTYDSKRVC FKEAVFSLLP RMRYGLFYNT PLISGCQNTG LFRAFAQHVL HRLNITQEGP
     KDGKIRVTIL ARSTEYRKIL NQNELVNALK TVSTFEVQIV DYKYRELGFL DQLRITHNTD
     IFIGMHGAGL THLLFLPDWA AVFELYNCED ERCYLDLARL RGVHYITWRR QNKVFPQDKG
     HHPTLGEHPK FTNYSFDVEE FMYLVLQAAD HVLQHPKWPF KKKHDEL
//
